Close
4

Seqens Seqens

X

Company profile for Diamyd Medical AB

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. Two disease-modifying therapies are being developed, the antigen-specific immunotherapy Diamyd® and the oral regenerative and immunomodulatory therapy Remygen®. Diamyd® and Remygen® target the underlying causes of diabetes, the dysfunction and loss of the pancreatic beta cells. Diamyd® and Remygen® are current...
Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. Two disease-modifying therapies are being developed, the antigen-specific immunotherapy Diamyd® and the oral regenerative and immunomodulatory therapy Remygen®. Diamyd® and Remygen® target the underlying causes of diabetes, the dysfunction and loss of the pancreatic beta cells. Diamyd® and Remygen® are currently being evaluated in clinical trials. Diamyd Medical’s shares are traded on Nasdaq First North, ticker DMYD B.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Diamyd Medical AB
Sweden Flag
Country
Country
Sweden
Address
Address
Kungsgatan 29, SE-111 56 Stockholm, Sweden
Telephone
Telephone
+46 8 661 00 26
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY